Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick #1 Aldeyra Therapeutuics; NDA Resubmission Reproxalap Plus Phase 2 Data Alcoholic Hepatitis 2nd Half Of 2024, Cash Beyond 2026 ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #1 is a biotech by the name of Aldeyra Therapeutics (ALDX). The reason why i want to go over this biotech ...
Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Old Pick#4 Cardiff Oncology; Positive Onvansertib Data RAS Mutant mCRC, Additional Data From Same Study 1st Half 2025 And Catalysts

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Old Pick #4 is a biotech by the name of Cardiff Oncology (CRDF). The reason why I wanted to go over this ...
GEN

Atelerix Inks Advanced Organoid Model Deal with Cherry Biotech

Atelerix, a biotech company working on cell preservation and biological transport with its hydrogel encapsulation technology, entered a partnership with Cherry Biotech, a French company specializing ...
Morningstar%2c Inc.

ARTHEx Biotech Publishes First Demonstration of Improvement in a DM1-related Behavioral Alteration in a Preclinical Model of Myotonic Dystrophy Type 1 (DM1)

New data show systemic delivery of antimiR-23b developed on ARTHEx BOOST-ON™ platform reaches the brain, corrects disease biology, and improves behavior—highlighting potential to address CNS ...